Sio Gene Therapies (SIOX) Stock Price, News & Analysis

Company Overview

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.

Key Stats

• Today's Range: $0.45 to $0.48
• 50-Day Range: $0.38 to $0.48
• 52-Week Range: $0.25 to $0.50
• Volume: 40,400 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SIOX Stock Analysis - Frequently Asked Questions

How were Sio Gene Therapies' earnings last quarter?

Sio Gene Therapies Inc. (NASDAQ:SIOX) announced its earnings results on Friday, November, 12th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.17) by $0.12.

When did Sio Gene Therapies' stock split?

Sio Gene Therapies shares reverse split on the morning of Wednesday, May 8th 2019. The 1-8 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

What other stocks do shareholders of Sio Gene Therapies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sio Gene Therapies investors own include Block (SQ), Digital Turbine (APPS), CrowdStrike (CRWD), ChargePoint (CHPT), Vuzix (VUZI) and Okta (OKTA).

Company Calendar

• Last Earnings: 11/12/2021
• Today: 12/22/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SIOX
• CUSIP: N/A
• CIK: 1636050
• Web: siogtx.com
• Phone: (646) 677-6770
• Fax: N/A
• Employees: 12
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: No Data
• Beta: N/A